ROS-mediated SRMS activation confers platinum resistance in ovarian cancerYunhan Jiang(The University of Texas Health Science Center at San Antonio), Lingtao Jin(The University of Texas Health Science Center at San Antonio)OncogeneApril 5, 202310.1038/s41388-023-02679-6Cited by 14SaveCiteExport RISWatch citationsRelated PapersEx vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine|Lung Cancer|2024|21<em>Ex Vivo</em> Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized Medicine|Preprints.org|2023|0